600 related articles for article (PubMed ID: 15687112)
21. Effects of acetate during regular hemodialysis.
Scheppach W; Kortmann B; Burghardt W; Keller F; Kasper H; Bahner U; Teschner M; Heidland A
Clin Nephrol; 1988 Jan; 29(1):19-27. PubMed ID: 3383461
[TBL] [Abstract][Full Text] [Related]
22. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease.
Gutierrez R; Schlessinger F; Oster JR; Rietberg B; Perez GO
Miner Electrolyte Metab; 1991; 17(5):297-302. PubMed ID: 1668124
[TBL] [Abstract][Full Text] [Related]
23. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
[TBL] [Abstract][Full Text] [Related]
24. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
25. [Hemodialysis with bicarbonate 30 mEq/l versus 34 mEq/l and acetate: better hemodynamic tolerance and electrolyte and acid-base homeostasis].
Bruges M; Barata JD; Oliveira C; Furstenau C; Gomes EM; Simões J
Acta Med Port; 1994 Mar; 7(3):165-70. PubMed ID: 8209702
[TBL] [Abstract][Full Text] [Related]
26. [Bicarbonate hemodialysis in the therapy of chronic kidney failure].
Riabov SI; Shostka GD; Spiridonov VN; Vasil'ev AN; Kozlov VV
Ter Arkh; 1988; 60(5):76-80. PubMed ID: 3175934
[TBL] [Abstract][Full Text] [Related]
27. [Cardiovascular risk markers in hemodialysis].
Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
[TBL] [Abstract][Full Text] [Related]
28. Spirometry parameters in patients undergoing hemodialysis with bicarbonate and acetate dialysates.
Navari K; Farshidi H; Pour-Reza-Gholi F; Nafar M; Zand S; Sohrab Pour H; Eqbal Eftekhaari T
Iran J Kidney Dis; 2008 Jul; 2(3):149-53. PubMed ID: 19377229
[TBL] [Abstract][Full Text] [Related]
29. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
30. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
[TBL] [Abstract][Full Text] [Related]
31. Electrocardiography and serum potassium before and after hemodialysis sessions.
Tarif N; Yamani H; Bakhsh AJ; Al-Wakeel JS; Sulaimani F; Memon NA; Al Suwaida AK
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):47-53. PubMed ID: 18087122
[TBL] [Abstract][Full Text] [Related]
32. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
33. The influence of low dialysate sodium and glucose concentration on volume distributions in body compartments after haemodialysis: a bioimpedance analysis study.
Ozturk S; Taymez DG; Bahat G; Demirel R; Yazici H; Aysuna N; Sakar S; Yildiz A
Nephrol Dial Transplant; 2008 Nov; 23(11):3629-34. PubMed ID: 18508835
[TBL] [Abstract][Full Text] [Related]
34. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function.
Garthwaite E; Bhandari S
Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582
[TBL] [Abstract][Full Text] [Related]
35. Length of interdialytic interval influences serum calcium and phosphorus concentrations.
Sigrist MK; Devlin L; Taal MW; Fluck RJ; McIntyre CW
Nephrol Dial Transplant; 2005 Aug; 20(8):1643-6. PubMed ID: 15870223
[TBL] [Abstract][Full Text] [Related]
36. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
[TBL] [Abstract][Full Text] [Related]
37. [Non-pharmacological calcium metabolism control in patients undergoing hemodialysis].
Malberti F
G Ital Nefrol; 2009; 26(6):670-8. PubMed ID: 19918749
[TBL] [Abstract][Full Text] [Related]
38. [Acid-base balance in haemodialyzed patients].
Hrabcáková P; Mydlík M; Molcányiová A
Vnitr Lek; 2002 Oct; 48(10):959-61. PubMed ID: 16737145
[TBL] [Abstract][Full Text] [Related]
39. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
Krämer BK; Ress KM; Ulshöfer TM; Risler T
Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
[TBL] [Abstract][Full Text] [Related]
40. Automated regional citrate anticoagulation: technological barriers and possible solutions.
Szamosfalvi B; Frinak S; Yee J
Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
